Huawei has been trusted by the European Society of Cardiology ESC, as the European Society of Cardiology ESC Guidelines 2020 for the Diagnosis and Management of Atrial Fibrillation, a common heart rhythm disorder, published during the ESC Congress 2020 annual cardiovascular main event cited the HUAWEI Heart Study Study) in recognition of the effectiveness of Huawei wearables including the HUAWEI WATCH GT 2 Pro, HUAWEI WATCH FIT and HUAWEI Band 4 Series in detecting the atria. ESC guidelines incorporate new scientific findings and evidence with the goal of helping healthcare professionals suggest the best recommendations for managing atrial fibrillation.
The HUAWEI Heart Study is a co-sponsored Huawei research study by Huawei and 301 Hospital in China. The study examines the application of smart wearable technology in cardiovascular disease management, and benefits from the experience of participating sponsors in their respective fields. The results of the ongoing study were presented at several world healthcare conferences and prestigious medical journals, including the Journal of the American College of Cardiology and the European Journal of Cardiology in April and May 2020 respectively.
As reported in the ESC Guidelines for 2020, in the HUAWEI Heart Study, 187,912 individuals used Huawei wearable products in conjunction with the hospital’s 301 Hospital Mobile Atrial Fibrillation (mAFA) app to monitor heart rhythm. Of these participants, 0.23 percent received a notification of “suspected atrial fibrillation” and of those who followed, 87 percent were confirmed to have atrial fibrillation 3, demonstrating the effectiveness of the solution in identifying patients with the disorder. Moreover, 95.1% of the diagnosed users were referred to the mAFA platform for atrial fibrillation management services provided by the 301 AF Management Center Hospital.
Huawei offers heart rate monitoring and a list of health tracking features through its smart wearable products, which include the HUAWEI WATCH GT 2 Pro, HUAWEI WATCT FIT, HUAWEI Band 4 Series and beyond. Looking to the future, Huawei, through its research – HUAWEI Research, and 301 Hospital will continue to work together to conduct health research and explore new ways to integrate technology that enables better and more convenient access to remote healthcare.
These were the details of the news The Huawei Heart Study wins Huawei’s wearable products approved by the... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at eg24.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.